Nevada reverses block on rapid COVID-19 tests in nursing homes

Nevada assisted living home were ordered by the state to stop using Quidel or Becton, Dickinson and Co. fast tests Oct. 2 due to issues about false-positive results..

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this content? View our policies by clicking here.

In action to an order from the Trump administration, Nevada has actually reversed an order obstructing nursing houses from utilizing federally supplied rapid COVID-19 antigen tests, reports The Wall Street Journal..

More short articles on post-acute care: Deaths of 2 homeowners at North Carolina retirement home thought about murders, police sayNearly 60% of patients at Connecticut assisted living home test positive for COVID-1923 New York nursing houses fined $328K for COVID-19 safety offenses.

” We are extremely dissatisfied by the letter received today from U.S. HHS Giroir, as our objective remains unified in securing those most vulnerable in our communities,” stated Ihsan Azzam, MD, PhD, Nevadas CMO. “We too want more testing with rapid turnaround in Nevada, however the outcomes of those tests must be precise as they affect medical care.”.

Dr. Giroir safeguarded the federally supplied tests on an Oct. 9 call with press reporters, saying the false-positive rate was low and the concern could be managed by using proper treatments to confirm outcomes..

In an Oct. 8 letter to state authorities, Adm. Brett Giroir, MD, HHS assistant secretary for health, stated the Nevada ban was “inconsistent with and preempted by federal law and, as such, should stop right away or suitable action will be taken versus those included.”.

Gabrielle Masson –
Monday, October 12th, 2020
Print|Email.

© Copyright ASC COMMUNICATIONS 2020. Intrigued in LINKING to or REPRINTING this content? View our policies by clicking here.

” We are not saying the tests have no usage, we are just stating time out for further review and additional training,” Dr. Azzam stated. The department launched an Oct. 9 bulletin advising houses continue to carry out follow-up lab-based molecular tests for all outcomes..